trastuzumab,pertuzumab
roche
['phergain']
phergain 80% with preop hp had early pet response, 38% w/ pcr #asco23 
Translational Medical Oncologist & Big Data Science, Toxicities & Outcomes Research; #COVID19; @OncoAlert; FASCO & ASCO Biomarkers. “Let's make a difference".